RECK-mediated inhibition of glioma migration and invasion

Journal of Cellular Biochemistry

Volumn 110, Issue 1, 2010, Pages 52-61

  Corrêa, Tatiana C Silveira ^a   Massaro, Renato Ramos ^a   Brohem, Carla Abdo ^a   Taboga, Sebastião Roberto ^b   Lamers, Marcelo Lazzaron ^a,c   Santos, Marinilce Fagundes ^a   Maria Engler, Silvya Stuchi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cytoskeleton; Glioblastoma; Invasion; Migration; MMP; Reck gene

Indexed keywords

ACTIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MYOSIN II; PROTEIN RECK; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; ANTITUMOR GENE; ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME PHOSPHORYLATION; GLIOMA; HUMAN; HUMAN CELL; LAMELLIPODIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECK GENE; STRESS FIBER;

CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTEIN TRANSPORT; TUMOR STEM CELL ASSAY;

EID: 77951709114     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22472     Document Type: Article

References (40)

1. Aubert M, Badoual M, Christov C, Grammaticos B. 2008. A model for glioma cell migration on collagen and astrocytes. J R Soc Interface 18:75-83. (Pubitemid 350159185)
2. Corrêa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS. 2006. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness. J Cell Biochem 99(1):156-167.
3. Echizenya M, Kondo S, Takahashi R, Oh J, Kawashima S, Kitayama H, Takahashi C, Noda M. 2005. The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors. Oncogene 38:5850-5857.
4. Fiebig HH, Maier A, Burger AM. 2004. Clonogenic assay with established human tumour xenografts: Correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. Eur J Cancer 40(6):802-820. (Pubitemid 38519759)
5. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315-2319.
6. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. 2008. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 17:5369-5380.
7. Galardy RE, Cassabonne ME, Giese C, Gilbert JH, Lapierre F, Lopez H, Schaefer ME, Stack R, Sullivan M, Summers B. 1994. Low molecular weight inhibitors in corneal ulceration. Ann N Y Acad Sci 732:315-323.
8. Giese A, Bjerkvig R, Berens ME, Westphal M. 2003. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 21(8):1624-1636. (Pubitemid 46594118)
9. Golubovskaya VM, Kweh FA, Cance WG. 2009. Focal adhesion kinase and cancer. Histol Histopathol 24(4):503-510.
10. Honma K, Miyata T, Ochiya T. 2007. Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells. Cancer Cell Int 7:12. (Pubitemid 47161707)
11. Iwamaru A, Kondo Y, Iwado E, Aoki H, Fujiwara K, Yokoyama T, Mills GB, Kondo S. 2007. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene 26(13):1840-1851. (Pubitemid 46474638)
12. Kondo S, Shukunami C, Morioka Y, Matsumoto N, Takahashi R, Oh J, Atsumi T, Umezawa A, Kudo A, Kitayama H, Hiraki Y, Noda M. 2007. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci 120(Pt 5):849-857. (Pubitemid 46523486)
13. Lassman AB, Holland E. 2007. Incorporating molecular tools into clinical trials and treatment for gliomas? Curr Opin Neurol 20(6):708-711.
14. Levicar N, Nuttall RK, Lah TT. 2003. Proteases in brain tumour progression. Acta Neurochir 145(9):825-838.
15. Liang CC, Park AY, Guan JL. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329-333.
16. Liu LT, Chang HC, Chiang LC, Hung WC. 2002. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells. Oncogene 21(54):8347-8350. (Pubitemid 35477875)
17. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods, 25(4):402-408. (Pubitemid 34164012)
18. Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ. 1997. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem 272:5007-5015. (Pubitemid 27090053)
19. Lopez-Otìn C, Matrisian LM. 2007. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7(10):800-808. (Pubitemid 47463671)
20. Louis DN. 2006. Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97-117.
21. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M. 2003. RECK expression in pancreatic cancer: Its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9(5): 1779-1784. (Pubitemid 36554604)
22. Miki T, Takegami Y, Okawa K, Muraguchi T, Noda M, Takahashi C. 2007. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem 282(16):12341-12352. (Pubitemid 47100672)
23. Morioka Y, Monypenny J, Matsuzaki T, Shi S, Alexander DB, Kitayama H, Noda M. 2009. The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28(11):1454-1464.
24. Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EP, Omura A, Miki T, Takahashi R, Matsumoto N, Ludwig A, Noda M, Takahashi C. 2007. RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci 10(7): 838-845. (Pubitemid 47013438)
25. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108(2):193-199.
26. Noda M, Takahashi C. 2007. Recklessness as a hallmark of aggressive cancer. Cancer Sci 98(11):1659-1665.
27. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. 2001. The membrane-anchored MMp inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107(6):789-800.
28. Omura A, Matsuzaki T, Mio K, Ogura T, Yamamoto M, Fujita A, Okawa K, Kitayama H, Takahashi C, Sato C, Noda M. 2008. Reck forms cowbell-shaped dimers and inhibits MMP-catalyzed cleavage of fibronectin. J Biol Chem 284(6):3461-3469.
29. Paulissen G, Rocks N, Quesada-Calvo F, Gosset P, Foidart JM, Noel A, Louis R, Cataldo DD. 2006. Expression of ADAMs and their inhibitors in sputum from patients with asthma. Mol Med 12(7-8):171-179. (Pubitemid 44646346)
30. Sasahara RM, Brochado SM, Takahashi C, Oh J, Maria-Engler SS, Granjeiro JM, Noda M, Sogayar MC. 2002. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect Prev 26(6):435-443. (Pubitemid 36035373)
31. Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, Ohmori O, Bigner DD, Friedman HS, Rich JN. 2007. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 46(6):488-496. (Pubitemid 46897053)
32. Small JV, Auinger S, Nemethova M, Koestler S, Goldie KN, Hoenger A, Resch GP. 2008. Unravelling the structure of the lamellipodium. J Microsc 231(3):479-485.
33. Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL. 2003. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: A prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97(11):2710-2715. (Pubitemid 36605137)
34. Takagi S, Hoshino Y, Osaki T, Okumura M, Fuginaga T. 2007. Expression of membrane-anchored matrix metalloproteinase inhibitor reversion inducing cysteine rich protein with Kazal motifs in murine cell lines. Exp Oncol 29(1):30-34. (Pubitemid 46713476)
35. Takagi S, Simizu S, Osada H. 2009. RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res 69(4):1502-1508.
36. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. 1998. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95(22):13221-13226. (Pubitemid 28509552)
37. Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F. 2005. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Ann Surg Oncol 12(10): 817-824. (Pubitemid 41355934)
38. Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y. 2004. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res 10(16):5572-5579. (Pubitemid 39100498)
39. van Lent PL, Span PN, Sloetjes AW, Radstake TR, van Lieshout AW, Heuvel JJ, Sweep CG, van den Berg WB. 2005. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis. Ann Rheum Dis 64(3):368-374.
40. Welm B, Mott J, Werb Z. 2002. Developmental biology: Vasculogenesis is a wreck without RECK. Curr Biol 12(6):R209-R211.